The company, whose repertoire includes arthroscopy equipment, said sales for the third quarter that ended Sept. 30, 2009 were $175.5 million, compared with $179.4 million in the same quarter of 2008.
However, third quarter results “were substantially better than we had anticipated,” said Joseph Corasanti, president and CEO, and represented an $11 million increase over the second quarter.
Read the release on Conmed’s third quarter report.